Biogen’s Aduhelm Price Tag Too High Says ICER
The Institute for Clinical and Economic Review (ICER) published a revised report on Biogen’s Aduhelm. The drug is designed for [...]
ICER to Assess Alzheimer’s Treatment
Today the Institute for Clinical and Economic Review (ICER) announced that it will assess the comparative clinical effectiveness and value [...]
